KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 123 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $261,000 | +7.9% | 44,545 | -2.4% | 0.00% | – |
| Q3 2016 | $242,000 | -15.4% | 45,653 | +5.6% | 0.00% | – |
| Q2 2016 | $286,000 | +28.3% | 43,240 | -9.6% | 0.00% | – |
| Q1 2016 | $223,000 | -1.3% | 47,842 | +6.9% | 0.00% | – |
| Q4 2015 | $226,000 | -2.2% | 44,734 | -31.9% | 0.00% | – |
| Q3 2015 | $231,000 | -72.0% | 65,736 | -20.6% | 0.00% | -100.0% |
| Q2 2015 | $826,000 | +3.2% | 82,797 | +31.7% | 0.00% | 0.0% |
| Q1 2015 | $800,000 | +13.8% | 62,877 | +26.5% | 0.00% | 0.0% |
| Q4 2014 | $703,000 | -1.8% | 49,697 | -4.6% | 0.00% | 0.0% |
| Q3 2014 | $716,000 | -25.4% | 52,071 | -16.6% | 0.00% | 0.0% |
| Q2 2014 | $960,000 | -49.1% | 62,432 | -43.6% | 0.00% | -50.0% |
| Q1 2014 | $1,887,000 | +173.1% | 110,729 | +107.5% | 0.00% | +100.0% |
| Q4 2013 | $691,000 | +36.8% | 53,361 | +6.6% | 0.00% | 0.0% |
| Q3 2013 | $505,000 | -93.5% | 50,077 | -95.2% | 0.00% | -87.5% |
| Q2 2013 | $7,797,000 | – | 1,043,817 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |